A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study

Saved in:

Bibliographic Details
Published in	Gynecologic oncology Vol. 133; p. 3
Main Authors	Miller, A, O'Malley, D.M, Mannel, R.S, Behbakht, K, Bakkum-Gamez, J.N, Michael, H
Format	Journal Article
Language	English
Published	Elsevier Inc 01.06.2014
Subjects	Hematology, Oncology and Palliative Medicine Obstetrics and Gynecology
Online Access	Get full text

Loading…

More Information
ISSN:	0090-8258 1095-6859
DOI:	10.1016/j.ygyno.2014.03.022